Inventor · disambiguated record
Irene Griswold-Prenner
Also filed as: GRISWOLD-PRENNER IRENE
15 granted patents·14 pending applications·199 citations·filing 2004–2022
93Inventor score
Files withIPIERIAN INC15ELAN PHARM INC6IMAGO PHARMACEUTICALS INC3NITRASE THERAPEUTICS INC2BIX GREGORY J1
Top patents by PatentIndex Score
29 records- 0197US9777058B2Methods of treating a tauopathyIPIERIAN INC·Filed 2016·Granted Oct 3, 2017·12 cites·15 claims
- 0297US9447180B2Methods of treating a tauopathyIPIERIAN INC·Filed 2015·Granted Sep 20, 2016·15 cites·27 claims
- 0397US9051367B2Methods of treating a tauopathyIPIERIAN INC·Filed 2014·Granted Jun 9, 2015·33 cites·22 claims
- 0497US8980271B2Methods of treating a tauopathyIPIERIAN INC·Filed 2014·Granted Mar 17, 2015·32 cites·21 claims
- 0597US8980270B2Methods of treating a tauopathyIPIERIAN INC·Filed 2014·Granted Mar 17, 2015·33 cites·50 claims
- 0693US9567395B2Methods of treating a tauopathyIPIERIAN INC·Filed 2013·Granted Feb 14, 2017·16 cites·16 claims
- 0793US8926974B2Methods of treating a tauopathyIPIERIAN INC·Filed 2013·Granted Jan 6, 2015·45 cites·28 claims
- 0890US10040847B2Methods of treating a tauopathyIPIERIAN INC·Filed 2017·Granted Aug 7, 2018·6 cites·75 claims
- 0980US10766954B2Therapeutic antibodies for treatment of neurodegenerationIMAGO PHARMACEUTICALS INC·Filed 2017·Granted Sep 8, 2020·2 cites·12 claims
- 1079US7901683B2Methods of inhibiting amyloid toxicityELAN PHARM INC·Filed 2008·Granted Mar 8, 2011·3 cites·21 claims
- 1168US2009227656A1Methods for using modulators of proline-rich tyrosine kinase 2ELAN PHARM INC·Filed 2009·Application pending·0 cites
- 1267US10400018B2Tau peptides, anti-tau antibodies, and methods of use thereofIPIERIAN INC·Filed 2014·Granted Sep 3, 2019·1 cites·32 claims
- 1365US2019169275A1Methods of Treating a TauopathyIPIERIAN INC·Filed 2018·Application pending·0 cites
- 1463US2014099304A1Methods of Treating a TauopathyIPIERIAN INC·Filed 2013·Application pending·0 cites
- 1563US2014099303A1Methods of Treating a TauopathyIPIERIAN INC·Filed 2013·Application pending·0 cites
- 1659US7674597B2Signaling intermediates in an in vitro model of Alzheimer's diseaseELAN PHARM INC·Filed 2005·Granted Mar 9, 2010·1 cites·1 claims
- 1758US2020102375A1Methods of Treating a TauopathyIPIERIAN INC·Filed 2019·Application pending·0 cites
- 1857US2020385450A1Therapeutic antibodies for treatment of neurodegenerationIMAGO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1955US2008300206A1Alpha-Synuclein KinaseELAN PHARM INC·Filed 2008·Application pending·0 cites
- 2054US2016289309A1Methods of treating a tauopathyIPIERIAN INC·Filed 2014·Application pending·0 cites
- 2153US7829087B2Methods of treating cognitive impairmentELAN PHARM INC·Filed 2007·Granted Nov 9, 2010·0 cites·16 claims
- 2250US2025012814A1Methods of diagnosing a synucleinopathyNITRASE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2349US2005059621A1Methods for using modulators of proline-rich tyrosine kinase 2Filed 2004·Application pending·0 cites
- 2446US2011207796A1Alpha-synuclein kinaseELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 2544US2016122421A1Methods of treating a tauopathyIPIERIAN INC·Filed 2014·Application pending·0 cites
- 2643US2019231751A1Treatment of fibrotic disorders with jun n-terminal kinase inhibitorsIMAGO PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2741US12071649B1Identification of modulators of nitration and therapeutic uses thereofNITRASE THERAPEUTICS INC·Filed 2018·Granted Aug 27, 2024·0 cites·10 claims
- 2839US9358273B2Use of perlecan domain V in treating amyloidogenic diseaseBIX GREGORY J·Filed 2011·Granted Jun 7, 2016·0 cites·26 claims
- 2939US2010303824A1Signaling intermediates in an in vitro model of alzheimer's diseaseELAN PHARM INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Irene Griswold-Prenner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →